NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 53 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | -100.0% | 176 | -99.6% | 0.00% | – |
| Q1 2022 | $88,000 | +417.6% | 47,292 | +1204.2% | 0.00% | – |
| Q4 2021 | $17,000 | +1600.0% | 3,626 | +3526.0% | 0.00% | – |
| Q1 2021 | $1,000 | -87.5% | 100 | -83.5% | 0.00% | – |
| Q4 2020 | $8,000 | -20.0% | 605 | -33.5% | 0.00% | – |
| Q3 2020 | $10,000 | +11.1% | 910 | +9.0% | 0.00% | – |
| Q1 2020 | $9,000 | +200.0% | 835 | -22.8% | 0.00% | – |
| Q3 2019 | $3,000 | – | 1,082 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,047,300 | $5,048,000 | 1.07% |
| ACT CAPITAL MANAGEMENT, LLC | 212,500 | $1,024,000 | 0.74% |
| Redmile Group, LLC | 3,490,835 | $16,826,000 | 0.38% |
| Kynam Capital Management, LP | 147,000 | $709,000 | 0.38% |
| EcoR1 Capital, LLC | 860,619 | $4,148,000 | 0.13% |
| Baker Brothers Advisors | 3,821,740 | $18,421,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 130,899 | $631,000 | 0.08% |
| Sio Capital Management, LLC | 38,312 | $185,000 | 0.06% |
| Highland Private Wealth Management | 46,999 | $227,000 | 0.03% |
| XTX Topco Ltd | 10,018 | $48,000 | 0.03% |